跳至主要内容
临床试验/NCT02237118
NCT02237118已完成不适用

Prospective, Randomized, Non-inferiority Investigation to Compare Effects of Mepitel® One and UrgoTul® Dressings in Acute Wound Management (Only)"

Molnlycke Health Care AB1 个研究点 分布在 1 个国家目标入组 123 人开始时间: 2014年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
123
试验地点
1
主要终点
Number of Participants With Non-Painful Dressing Removal, Measured by Visual Aanalog Scale (VAS)

研究概览

简要总结

To compare the effects of pain of the two dressings, Mepitel® One and UrgoTul® in acute wound management.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Acute wound: traumatic wound (dermabrasion, skin tears, other), benign burn requiring the use of dressings
  • •Acute wound size between 3 cm² and 240 cm2 (wound could be covered by 2 investigational products maximum)
  • •Wound whose duration is ≤ 3 days
  • •Both gender with an age ≥ 18 years
  • •Subject able to understand and voluntarily sign the informed consent
  • •Subject able to follow the protocol
  • •Subject insured to the French social security system

排除标准

  • •Surgical wound
  • •Infected, moderately to strongly exudative and haemorrhagic wound
  • •Diagnosed underlying disease (e.g. diabetic neuropathy, stroke, ...) which, as judged by the investigator, could interfere with the pain assessment
  • •Known allergy/hypersensitivity to any of the components of the investigational products
  • •Participation in other clinical investigation within one month prior to start of investigation
  • •Pregnant or breast-feeding women
  • •Person protected by a legal regime (tutorship or guardianship)

研究组 & 干预措施

UrgoTul

Active Comparator

Pain on removal by VAS

干预措施: Mepitel One (Device)

UrgoTul

Active Comparator

Pain on removal by VAS

干预措施: UrgoTul (Device)

Mepitel One

Active Comparator

Pain on dressing removal, by VAS

干预措施: Mepitel One (Device)

Mepitel One

Active Comparator

Pain on dressing removal, by VAS

干预措施: UrgoTul (Device)

结局指标

主要结局

Number of Participants With Non-Painful Dressing Removal, Measured by Visual Aanalog Scale (VAS)

时间窗: 21 days

To compare the effects of pain of the two dressings, Mepitel® One and UrgoTul®, during the first dressing removal. Pain measured by VAS Score ≥ 30 mm on the 100 mm VAS scale are reported.

次要结局

  • Assessment of the Surrounding Skin.(21 days)
  • Condition of the Wound, Will be Assesst by the Investigator.(21 days)
  • Safety(21 days)
  • Complete Healing at Day 21, Will be Measured Using PictZar ( Digital Planimetric System) System.(21 days)

研究者

发起方
Molnlycke Health Care AB
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验